Description
An atypical antipsychotic; an inverse agonist of dopamine D2 and D3 receptors (IC50s = 1 and 0.9 nM, respectively) as well as an antagonist at these receptors (Kis = 0.4 and 0.1 nM, respectively); binds to α1- and α2-adrenergic receptors, histamine H1 receptors, and the 5-HT receptor subtypes 5-HT1A , 5-HT1D, 5-HT2A, and 5-HT2C (Kds = 10.1, 80, 3.4, 480, 19, 1.21, and 48 nM, respectively); improves spatial working memory in a T-maze alternation task in a maternal immune activation mouse model of schizophrenia at 0.05 mg/kg per day; an active metabolite of risperidone,,
Formal name: 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Synonyms: 9-hydroxy Risperidone|RO76477
Molecular weight: 426.5
CAS: 144598-75-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Receptor Pharmacology|Inverse Agonists||Research Area|Neuroscience|Behavioral Neuroscience|Bipolar Disorder||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis